Thiazolidinediones are associated with a reduced risk of COPD exacerbations

BACKGROUND: Thiazolidinediones (TZDs) are oral antihyperglycemic medications that are selective agonists to peroxisome proliferator-activated receptor gamma and have been shown to have potent anti-inflammatory effects in the lung. OBJECTIVE: The purpose of this study was to assess whether exposure t...

Descripción completa

Detalles Bibliográficos
Autores principales: Rinne, Seppo T, Liu, Chuan-Fen, Feemster, Laura C, Collins, Bridget F, Bryson, Christopher L, O’Riordan, Thomas G, Au, David H
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2015
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4536761/
https://www.ncbi.nlm.nih.gov/pubmed/26300638
http://dx.doi.org/10.2147/COPD.S82643

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4536761/
https://www.ncbi.nlm.nih.gov/pubmed/26300638
http://dx.doi.org/10.2147/COPD.S82643

Ejemplares similares